KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Change in Cash (2016 - 2025)

Historic Change in Cash for Charles River Laboratories International (CRL) over the last 17 years, with Q3 2025 value amounting to $24.5 million.

  • Charles River Laboratories International's Change in Cash fell 2009.4% to $24.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.4 million, marking a year-over-year decrease of 10525.81%. This contributed to the annual value of -$78.9 million for FY2024, which is 28238.34% down from last year.
  • Per Charles River Laboratories International's latest filing, its Change in Cash stood at $24.5 million for Q3 2025, which was down 2009.4% from -$47.0 million recorded in Q2 2025.
  • Charles River Laboratories International's 5-year Change in Cash high stood at $237.9 million for Q1 2021, and its period low was -$243.5 million during Q2 2021.
  • Moreover, its 5-year median value for Change in Cash was -$985000.0 (2021), whereas its average is -$1.3 million.
  • The largest annual percentage gain for Charles River Laboratories International's Change in Cash in the last 5 years was 26723.39% (2024), contrasted with its biggest fall of 13808508.77% (2024).
  • Charles River Laboratories International's Change in Cash (Quarter) stood at $19.8 million in 2021, then surged by 127.36% to $45.0 million in 2022, then soared by 163.93% to $118.9 million in 2023, then plummeted by 105.11% to -$6.1 million in 2024, then skyrocketed by 503.29% to $24.5 million in 2025.
  • Its last three reported values are $24.5 million in Q3 2025, -$47.0 million for Q2 2025, and $26.2 million during Q1 2025.